Drug intelligence / Profile preview

Cyhom-D

Development stage
Unknown
Lead developer
Cytech Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Cyhom-D is an oral fixed-dose combination capsule containing alpha-lipoic acid, methylcobalamin (vitamin B12), pyridoxine (vitamin B6), folic acid (vitamin B9), and vitamin D3 (cholecalciferol). Developed by Cytech Pharma, it is primarily used to treat and prevent nutritional deficiencies, support nerve health, and manage symptoms of neuropathy, including diabetic neuropathy. Alpha-lipoic acid acts as a potent antioxidant that protects nerves from oxidative stress, while methylcobalamin, pyridoxine, and folic acid support myelin sheath formation, nerve regeneration, and red blood cell production. Vitamin D3 regulates calcium metabolism and supports bone and muscle health.

Brand names
Cyhom-D
Other names
Methylcobalamin 1500mcg + Alpha-lipoic acid 100mg + Pyridoxine 3mg + Folic acid 1.5mg + Vitamin D3 1000IUalpha-lipoic acid + cholecalciferol + folic acid + methylcobalamin + pyridoxinealpha-lipoic acid + folic acid + methylcobalamin + pyridoxine + vitamin D3
02

Targets

DHFR (Dihydrofolate reductase)VDR (Vitamin D receptor)MTR (Methionine synthase)

Beyond the preview

Go deeper on Cyhom-D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyhom-D.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call